Evidence map›Paper›PMID 38373913›Full record

ArticleBMC microbiology2024

Difference analysis and characteristics of incompatibility group plasmid replicons in gram-negative bacteria with different antimicrobial phenotypes in Henan, China.

Ruyan Chen, Chenyu Li, Haoyu Ge, Jie Qiao, Lei Fang, Cailin Liu, Jianjun Gou, Xiaobing Guo

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Genomic characterisation and antimicrobial resistance ofFrontiers in cellular and infection microbiology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. ESBL-ProducingMicroorganisms · 2025
    Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ruyan Chen *Department of Laboratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Chenyu Li *Department of Laboratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Haoyu GeDepartment of Laboratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Jie QiaoDepartment of Laboratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Lei FangDepartment of Laboratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Cailin LiuDepartment of Laboratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Jianjun GouDepartment of Laboratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. jianjung@zzu.edu.cn.
Xiaobing GuoDepartment of Laboratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. gxbing928@zzu.edu.cn.
First Affiliated Hospital of Zhengzhou University · CN

Funding

Henan Provincial Science and Technology Research Project 232102310176
6 · The paper itself

Abstract

backgroundMulti-drug-resistant organisms (MDROs) in gram-negative bacteria have caused a global epidemic, especially the bacterial resistance to carbapenem agents. Plasmid is the common vehicle for carrying antimicrobial resistance genes (ARGs), and the transmission of plasmids is also one of the important reasons for the emergence of MDROs. Different incompatibility group plasmid replicons are highly correlated with the acquisition, dissemination, and evolution of resistance genes. Based on this, the study aims to identify relevant characteristics of various plasmids and provide a theoretical foundation for clinical anti-infection treatment.

methods330 gram-negative strains with different antimicrobial phenotypes from a tertiary hospital in Henan Province were included in this study to clarify the difference in incompatibility group plasmid replicons. Additionally, we combined the information from the PLSDB database to elaborate on the potential association between different plasmid replicons and ARGs. The VITEK mass spectrometer was used for species identification, and the VITEK-compact 2 automatic microbial system was used for the antimicrobial susceptibility test (AST). PCR-based replicon typing (PBRT) detected the plasmid profiles, and thirty-three different plasmid replicons were determined. All the carbapenem-resistant organisms (CROs) were tested for the carbapenemase genes.

results21 plasmid replicon types were detected in this experiment, with the highest prevalence of IncFII, IncFIB, IncR, and IncFIA. Notably, the detection rate of IncX3 plasmids in CROs is higher, which is different in strains with other antimicrobial phenotypes. The number of plasmid replicons they carried increased with the strain resistance increase. Enterobacterales took a higher number of plasmid replicons than other gram-negative bacteria. The same strain tends to have more than one plasmid replicon type. IncF-type plasmids tend to be associated with MDROs. Combined with PLSDB database analysis, IncFII and IncX3 are critical platforms for taking bla

conclusionsMDROs tend to carry more complex plasmid replicons compared with non-MDROs. The plasmid replicons that are predominantly prevalent and associated with ARGs differ in various species. The wide distribution of IncF-type plasmids and their close association with MDROs should deserve our attention. Further investigation into the critical role of plasmids in the carriage, evolution, and transmission of ARGs is needed.

Indexed as

Anti-Bacterial AgentsAnti-Infective Agentsbeta-LactamasesCarbapenemsGram-Negative BacteriaKlebsiella pneumoniaeMicrobial Sensitivity TestsPhenotypePlasmidsRepliconAnti-Bacterial AgentsAnti-Infective Agentsbeta-LactamasesCarbapenemsCarbapenem resistanceGram-negative bacteriaIncompatibility groupsPlasmid typing

Identifiers

PMID38373913
PMCPMC10875880
OpenAlexW4391931576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.